MM, R., CM, O., V, T., SE, F., G, G., E, D., . . . DM, W. (2019). Dolutegravir Use at Conception - Additional Surveillance Data from Botswana. The New England journal of medicine, 381(9), 885. https://doi.org/10.1056/NEJMc1908155
Chicago Style (17th ed.) CitationMM, Raesima, et al. "Dolutegravir Use at Conception - Additional Surveillance Data from Botswana." The New England Journal of Medicine 381, no. 9 (2019): 885. https://doi.org/10.1056/NEJMc1908155.
MLA (9th ed.) CitationMM, Raesima, et al. "Dolutegravir Use at Conception - Additional Surveillance Data from Botswana." The New England Journal of Medicine, vol. 381, no. 9, 2019, p. 885, https://doi.org/10.1056/NEJMc1908155.
Warning: These citations may not always be 100% accurate.